Trials / Recruiting
RecruitingNCT06967051
The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults
An Open Label Pilot Study Evaluating the Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Sobereye Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The goal of this open label study is to evaluate the efficacy of smart phone-based test (SOBEREYE OPTOVERA) on measuring pupillary light reflex (PLR) alterations following cannabis use healthy in adults. The main question it aims to answer is: Can SOBEREYE OPTOVERA detect PLR alterations following cannabis consumption in healthy adults, in comparison to a pupillometer? Participants will be given two 5 mg capsules to be ingested for the 10 mg THC dose or five 5 mg capsules to be ingested for the 25 mg THC. Participants will be asked to complete PLR tests throughout the study day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tetrahydrocannabinol (10 mg) | 10 mg of Tetrahydrocannabinol (THC) provided as a softgel capsule |
| DRUG | Tetrahydrocannabinol (25 mg) | 25 mg of THC provided as a softgel capsule. |
| DIAGNOSTIC_TEST | Pupillary Light Reflex (PLR) Test | SOBEREYE OPTOVERA is a portable, non-invasive test that measures the Pupillary Light Reflex (PLR) |
| DIAGNOSTIC_TEST | Pupillometer | NeuroLight is an automated pupillometer that generates a flash of light and measures the photomotor reflex very accurately. |
Timeline
- Start date
- 2025-05-22
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2025-05-13
- Last updated
- 2025-07-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06967051. Inclusion in this directory is not an endorsement.